NCT06439550 2024-06-03Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJCThe First Affiliated Hospital of Zhengzhou UniversityPhase 2 Not yet recruiting42 enrolled